Failure of pyrantel in treatment of human Hookworm infections (Ancylostoma duodenale) in the Kimberley region of North West Australia

Acta Tropica

Volumn 68, Issue 3, 1997, Pages 301-312

  Reynoldson, James A ^a   Behnke, Jerzy M ^b   Pallant, Louise J ^a   MacNish, Marion G ^a   Gilbert, Francis ^b   Giles, S ^c   Spargo, R J ^c   Andrew Thompson, R C ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NONE

Author keywords

Albendazole; Ancylostoma duodenale; Australian Aboriginal community; Chemotherapy; Giardia duodenalis; Pyrantel

Indexed keywords

ALBENDAZOLE; PYRANTEL EMBONATE;

ABORIGINE; ADOLESCENT; ANCYLOSTOMA DUODENALE; ARTICLE; AUSTRALIA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENTEROBIUS VERMICULARIS; FEMALE; GIARDIA DUODENALIS; HOOKWORM INFECTION; HUMAN; MALE; PRESCHOOL CHILD; STRONGYLOIDES STERCORALIS; TRICHURIS;

ADOLESCENT; ADULT; AGE FACTORS; ALBENDAZOLE; ANCYLOSTOMIASIS; ANTINEMATODAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PYRANTEL; SEX FACTORS; TREATMENT OUTCOME; WESTERN AUSTRALIA;

EID: 0031446782     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(97)00106-X     Document Type: Article

References (28)

1. Albonico M., Smith P.G., Hall A., Chwaya H.M., Alaw K.S., Savioli L. A randomised controlled trial comparing mebendazole and albendazole against Ascaris, Trichuris and hookworm infections. Trans. Roy. Soc. Trop. Med. Hyg. 88:1994;585-589.
2. Albonico M., Smith P.G., Ercole E., Hall A., Chwaya H.M., Alaw K.S., Savioli L. Trans. Roy. Soc. Trop. Med. Hyg. 89:1995;538-541.
3. Behnke J.M. Do hookworms elicit protective immunity in man? Parasitol. Today. 3:1987;200-206.
4. Behnke J.M., Pritchard D.I., Wakelin D., Park J.R., McNicholas A.M., Gilbert F.S. Effect of ivermectin on infection with gastro-intestinal nematodes in Sierra Leone. J. Helminth. 68:1994;187-195.
5. Coles G.C., Borgsteede F.H.M., Geerts S. Anthelmintic-resistant nematodes in the EU. Parasitol. Today. 10:1994;288-290.
6. Crawley, M.T., 1993. GLIM for Ecologists. Blackwell, Oxford.
7. De Clercq D., Sacko M., Behnke J.M., Gilbert F., Dorny P., Vercruysse J. Failure of mebendazole in treatment of human hookworm infections in the Southern Region of Mali. West Africa. Am. J. Trop. Med. Hyg. 57:1997;25-30.
8. Farahmandian I., Sahba G.H., Arfar F., Jabali H. A comparative evaluation of the therapeutic effect of pyrantel pamoate and bephenium hydroxynaphoate on Ancylostoma duodenale and other intestinal helminths. J. Trop. Med. Hyg. 75:1972;205-207.
9. Farid Z., Bassily S., Miner W.F., Hassan A., Laughlin L.W. Comparative single/dose treatment of hookworm and roundworm infections with levamisole, pyrantel and bephenium. J. Trop. Med. Hyg. 80:1977;107-108.
10. Geerts S., Coles G.C., Gryseels B. Anthelmintic resistance in human helminths: learning from the problems with worm control in livestock. Parasitol. Today. 13:1997;149-151.
11. Goldsmid J.M., Saunders R.C. Pyrantel pamoate for human hookworm infection. S. Afr. Med. J. 47:1973;25-26.
12. Haswell-Elkins M.R., Elkins D.B., Manjula K., Michael E., Anderson R.M. An investigation of hookworm infection and reinfection following mass anthelmintic treatment in the South Indian fishing community of Vairavankuppam. Parasitology. 96:1988;565-577.
13. Hopkins R.M., Gracey M., Hobbs R.P., Spargo R.M., Yates M., Thompson R.C.A. The prevalence of hookworm infection, iron deficiency and anaemia in an Aboriginal community in North-West Australia. Med. J. Aust. 166:1997;241-244.
14. Janssens, P.G., 1985. Chemotherapy of gastrointestinal nematodiasis in man. In: Vanden Bossche, H., Thienpont, D., Janssens, P.G. (Eds.), Chemotherapy of Gastrointestinal Helminths. Springer, Berlin, pp. 183-406.
15. Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Revt. Inst. Med. Trop. S. Paulo. 14:1972;397-400.
16. Lacey E. Mode of action of benzimidazoles. Parasitol. Today. 6:1990;112-115.
17. Mani G.G., Rao T.S., Madhavi R. Estimation of hookworm intensity by anthelmintic expulsion in primary schoolchildren in South India. Trans. Roy. Soc. Trop. Med. Hyg. 87:1993;634-635.
18. Meloni B.P., Thompson R.C.A., Hopkins R.M., Reynoldson, Gracey M. The prevalence of Giardia and other intestinal parasites in children, dogs and cats from Aboriginal communities in the Kimberley. Med. J. Aust. 158:1993;157-159.
19. Migasena, S., Gilles, H.M., 1991. Treatment of disease. In: Gilles, H.M., Ball, P.A.J., (Eds.), Human Parasitic Diseases, vol. 4, Hookworm Infections. Elsevier, Amsterdam, pp. 195-203.
20. Pene P., Mojon M., Garin J.P., Coulaud J.P., Rossignol J.F. Albendazole: a new broad spectrum anthelmintic. Double-blind multicenter clinical trial. Am. J. Trop. Med. Hyg. 31:1982;263-266.
21. Prociv P., Luke R.A. The changing epidemiology of human hookworm infection in Australia. Med. J. Aust. 162:1995;150-154.
22. Prociv P., Luke R.A. Evidence for larval hypobiosis in Australian strains of Ancylostoma duodenale. Trans. Roy. Soc. Trop. Med. Hyg. 89:1995;379.
23. Ramalingam S., Sinniah B., Krishnan U. Albendazole, an effective single dose, broad spectrum anthelmintic drug. Am. J. Trop. Med. Hyg. 32:1983;984-989.
24. Rossignol, J.F., 1990. Chemotherapy: present. In: Schad, G.A., Warren, K.S. (Eds.), Hookworm Disease, Current Status and New Directions. Taylor and Francis, London, pp. 281-290.
25. Rossignol J.F., Maisonneuve H. Albendazole: placebo-controlled study in 870 patients with intestinal helminthiasis. Trans. Roy. Soc. Trop. Med. Hyg. 17:1983;707-711.
26. Smith, G., 1990. Chemotherapy: future problems. In: Schad, G.A., Warren, K.S. (Eds.), Hookworm Disease, Current Status and New Directions. Taylor and Francis, London, pp. 291-303.
27. Waller P.J. Resistance in nematode parasites of livestock to the benzimidazole anthelmintics. Parasitol. Today. 6:1990;127-129.
28. World Health Organization, (1961) CCTA/WHO African conference on ancylostomiasis, Brazzaville, 22-29 August 1961. Tech. Rep. Ser. 1963; No. 225.